Flex Pharma, Inc. 4
4 · Flex Pharma, Inc. · Filed Jan 25, 2016
Insider Transaction Report
Form 4
Woo Elizabeth
VP, Investor Relations
Transactions
- Award
Stock Option (right to buy)
2016-01-21+40,000→ 40,000 totalExercise: $9.59Exp: 2026-01-21→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]25% of the total shares underlying this option vest on January 21, 2017 and the remaining shares vest 1/48 per month over the next 36 months thereafter, subject to continued service to the Issuer through each vesting date.